Co Diagnostics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Utah, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2401 S Foothill Dr Ste D, Salt Lake City...Phone Number
(801) 438-1036Website
www.co-dx.comRevenue
<$5 MillionStock Symbol
CODXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Co Diagnostics
Co-Diagnostics, Inc. is a molecular diagnostics company focused on the development, commercialization, and advancement of innovative diagnostic technologies designed to improve access to accurate, reliable, and affordable testing solutions. The company operates within the healthcare and life sciences sectors, specializing in molecular diagnostic products that support disease detection, clinical decision-making, research applications, and public health initiatives.Explore more
Co Diagnostics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Co Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Co Diagnostics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Co Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Co Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Co Diagnostics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Co Diagnostics launches new products
Funding: Get notified immidiatlly once Co Diagnostics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Co Diagnostics
Check out if Co Diagnostics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Co Diagnostics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Co Diagnostics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Co Diagnostics.
Co Diagnostics financials insights
Gather financial insights about Co Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Debt
$750K
2017
Stock Offering
$7.1M
2023
Grant
$2.3M
2026
Stock/Share Issuance
$3M
Co Diagnostics Tech Stack
A closer look at the technologies used by Co Diagnostics
See more technologies
Most Recent Scoops
Person-Based
Earnings, Clinical Operations, Finance
Project
Co Diagnostics has submitted a dual 510(k) and CLIA Waiver by application to the FDA for the Flu A/B and RSV assay on the CoDx PCR platform, marking a major regulatory milestone following years of development, validation, and regulatory preparation.
Clinical Operations
Project
Co Diagnostics has completed an analytical validation program comprising 27 individual studies and more than 10,000 upper respiratory PCR test runs on the CoDx PCR Pro, alongside a clinical study enrolling more than 1,400 symptomatic patients across nine geographically diverse sites throughout the United States.
Proof of Concept (POC), Medical Research, Clinical Operations
Project
Co Diagnostics has successfully completed a proof-of-concept study for an Ebola assay using direct-from-plasma as a sample type on the CoDx PCR Pro instrument, marking the company's first blood-based assay on the platform and demonstrating its versatility beyond traditional swab-based infectious disease testing.
Proof of Concept (POC), Medical Research, Pharmaceuticals
New Hire
Executive Move
Executive Moves, New Hire
Co Diagnostics News & Media
Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
Shipments of laboratory equipment and other mosquito abatement materials to overseas USAF base represent first international expansion of Vector Smart product line SALT LAKE CITY, Sept. 1, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular...Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
Company Chief Commercialization Officer represented Co-Dx in an event featuring other industry stakeholders held on August 13 in Salt Lake City, UT SALT LAKE CITY, Aug. 18, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company...Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call Transcript
Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call August 13, 2026 4:30 PM EDTCompany ParticipantsAndrew Benson - Head of Investor RelationsDwight Egan -...Co-Diagnostics Reports Second Quarter 2026 Financial Results
Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion Strengthening Integrated Co-Dx PCR Platform Through Scientific Innovation, Cloud Connectivity and AI-Enabled Capabilities SALT LAKE CITY, Aug. 13, 2026 /PRNewswire/ -- Co-Diagnostics,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Co Diagnostics
Sign Up For FreeTo access detailed company insights
Co-Diagnostics, Inc. is a molecular diagnostics company focused on the development, commercialization, and advancement of innovative diagnostic technologies designed to improve access to accurate, reliable, and affordable testing solutions. The company operates within the healthcare and life sciences sectors, specializing in molecular diagnostic pr... Read More
